Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Target Price
The average target price of PACB is 2.5 and suggests 49% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell